**Question:** Which of the following inhibit complex IV?

A. Ethidium bromide
B. Sodium dodecyl sulfate (SDS)
C. Probenecid
D. Nitrofurantoin

**Core Concept:**
The question is testing our understanding of the pharmacology of complex IV inhibition, which is a part of the electron transport chain (ETC) in mitochondria. The ETC is responsible for generating ATP (adenosine triphosphate) through the flow of electrons down their respective chains, with complex IV being the final and slowest step in this process. Complex IV, also known as cytochrome c oxidase, is a crucial enzyme involved in this process.

**Why the Correct Answer is Right:**
The correct answer, sodium dodecyl sulfate (SDS), is a detergent that disrupts the integrity of the mitochondrial membrane, leading to the inhibition of complex IV. Detergents like SDS bind to the negatively charged phospholipids in the mitochondrial membrane, causing destabilization and permeabilization of the membrane, ultimately impairing the function of the ETC, including complex IV.

**Why Each Wrong Option is Incorrect:**
A. Ethidium bromide is an intercalating agent that interferes with DNA replication and transcription, not affecting complex IV inhibition.
C. Probenecid is a uricosuric agent used to increase uric acid excretion in the kidneys, unrelated to mitochondrial function or complex IV inhibition.
D. Nitrofurantoin is an antibiotic mainly targeting the respiratory chain in bacteria, not affecting complex IV inhibition in mammalian cells.

**Clinical Pearl:**
Understanding complex IV inhibition is crucial for understanding the pharmacology of drugs targeting mitochondrial function, as well as the pathophysiology of diseases affecting mitochondrial function. Mitochondrial disorders, such as Leigh syndrome and Kearns-Sayre syndrome, are characterized by complex IV deficiency due to genetic mutations. Understanding the inhibition of complex IV can help guide clinical decision-making in the context of drug therapy and potential adverse effects.